FDA product code QOF: Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

QOF is the FDA product code for multi-target respiratory specimen nucleic acid test including sars-cov-2 and other microbial agents. It is a Class II device, regulated under 21 CFR 866.3981 and reviewed by the Microbiology panel. FDA has cleared 31 510(k) submissions under QOF, 31 in the last five years, from 17 different applicants. The average 510(k) review took 179 days (median 179); 190 days on average over the last three years. 1 De Novo request was granted under it. FDA has posted 8 recalls for QOF devices, 8 initiated in the last five years.

Definition

A device to detect and identify nucleic acid targets in respiratory specimens from microbial agents that cause the SARS-CoV-2 respiratory infection and other microbial agents when in a multi-target test is an in vitro diagnostic device intended for the detection and identification of SARS-CoV-2 and other microbial agents when in a multi-target test in human clinical respiratory specimens from patients suspected of respiratory infection who are at risk for exposure or who may have been exposed to these agents. The device is intended to aid in the diagnosis of respiratory infection in conjunction with other clinical, epidemiologic, and laboratory data or other risk factors.

Classification

FieldValue
Device nameMulti-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
Device classClass II
Regulation21 CFR 866.3981
Review panelMI — Microbiology
Medical specialtyMicrobiology
Premarket route510(k)

510(k) clearances per year for QOF

YearClearancesAvg. review days
20237212
20249144
202513174
20262252

Compare with all 510(k) review times · Search every QOF clearance

Top QOF applicants

ApplicantClearancesLatest
Biofire Diagnostics, LLC42025-08-14
Roche Molecular Systems, Inc.42025-07-31
Diasorin Molecular, LLC32025-12-23
QIAGEN GmbH32025-08-27
Cepheid®32025-05-01

12 more applicants have QOF clearances. See the full list in Caduvo.

Most recent QOF clearances

510(k)ApplicantDeviceDecision dateReview days
K252269Baebies, Inc.FINDER Flu A&B/SARS-CoV-2 Test2026-03-30252
K251742Lex Diagnostics LimitedVELO Respiratory Test2026-02-13252
K251978Diasorin Molecular, LLCLIAISON NES FLU A/B, RSV & COVID-192025-12-23179
K252387Diasorin Molecular, LLCSimplexa™ COVID-19/ Flu A/B & RSV Direct (MOL4450); Simplexa™ COVID-19/ Flu A/B & RSV Positive Control Pack (MOL4460)2025-10-3091
K250080QIAGEN GmbHQIAstat-Dx Respiratory Panel Plus; QIAstat-Dx Respiratory Panel Mini2025-08-27226

Recalls for QOF devices

8 product recalls in 8 recall events; 8 initiated in the last five years and 8 still open. Most recent: 2026-04-01.

YearRecalls
20233
20241
20253
20261

Frequently asked questions

What is FDA product code QOF?

QOF is the FDA product code for multi-target respiratory specimen nucleic acid test including sars-cov-2 and other microbial agents. It is a Class II device, regulated under 21 CFR 866.3981 and reviewed by the Microbiology panel.

What device class is QOF?

Class II, regulation 21 CFR 866.3981. Typical premarket route: 510(k).

How long does a 510(k) take for product code QOF?

Across 31 cleared submissions the average was 179 days from receipt to decision (median 179).

Which companies have the most QOF clearances?

Biofire Diagnostics, LLC (4); Roche Molecular Systems, Inc. (4); Diasorin Molecular, LLC (3); QIAGEN GmbH (3); Cepheid® (3).

Have QOF devices been recalled?

Yes: 8 product recalls across 8 recall events; the most recent began 2026-04-01.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times